Biotech · Private company
Sensei Biotherapeutics, Inc.
Track this companyFree. Adds Sensei Biotherapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- CemiplimabPhase 2 · Solid Tumor, AdultClinicalTrials.gov · fetched Nov 12, 2026
- PembrolizumabPhase 2 · Squamous Cell Carcinoma of the Head and NeckClinicalTrials.gov · fetched Nov 12, 2026
- SNS-101 (anti-VISTA)Phase 2 · Solid Tumor, AdultClinicalTrials.gov · fetched Nov 12, 2026
- SNS-301Phase 2 · Squamous Cell Carcinoma of the Head and NeckClinicalTrials.gov · fetched Nov 12, 2026
- PAN-301-1Phase 1 · Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid TumorsPHASE1_PHASE2 · COMPLETED · started May 31, 2023ClinicalTrials.gov NCT05864144 · fetched Nov 12, 2026
- Addition of SNS-301 to Checkpoint Inhibitor Treatment in Metastatic/Recurrent SCCHNPHASE1_PHASE2 · TERMINATED · started Nov 11, 2019ClinicalTrials.gov NCT04034225 · fetched Nov 12, 2026
- Phase 1 Trial of PAN-301-1 (SNS-301) in Cancer PatientsPHASE1 · COMPLETED · started Dec 1, 2016ClinicalTrials.gov NCT03120832 · fetched Nov 12, 2026